Contact
searchSearch
HMP Global

May 2011 - FRMC

Feature
Year of Exenatide Treatment Improves Baseline A1c Levels in Diabetic Patients
05/24/2011
Christin Melton
Minneapolis—In a single-arm, multicenter, observational study of patients in the United States with type 2 diabetes (T2D), twice-daily administration of exenatide was associated with significantly lower glycosylated hemoglobin (A1c) test...
Minneapolis—In a single-arm, multicenter, observational study of patients in the United States with type 2 diabetes (T2D), twice-daily administration of exenatide was associated with significantly lower glycosylated hemoglobin (A1c) test...
Minneapolis—In a single-arm,...
05/24/2011
First Report Managed Care
Department
Multiple Sclerosis Drug Pipeline Expanding
05/24/2011
Tim Casey
Minneapolis—When the US Food and Drug Administration (FDA) approved interferon beta-1b, a biotechnology product, in 1993, the treatment approach regarding multiple sclerosis (MS) changed, according to Gary M. Owens, MD, president of Gary...
Minneapolis—When the US Food and Drug Administration (FDA) approved interferon beta-1b, a biotechnology product, in 1993, the treatment approach regarding multiple sclerosis (MS) changed, according to Gary M. Owens, MD, president of Gary...
Minneapolis—When the US Food and...
05/24/2011
First Report Managed Care
Department
An Update on the Specialty Pharmaceuticals Pipeline
05/24/2011
Tori Socha
Minneapolis—In a contemporary issues session at the AMCP meeting titled Specialty Pharmaceuticals Pipeline Update, attendees heard from Aimee Tharaldson, PharmD, senior clinical consultant, emerging therapeutics, at Express Scripts. Dr....
Minneapolis—In a contemporary issues session at the AMCP meeting titled Specialty Pharmaceuticals Pipeline Update, attendees heard from Aimee Tharaldson, PharmD, senior clinical consultant, emerging therapeutics, at Express Scripts. Dr....
Minneapolis—In a contemporary...
05/24/2011
First Report Managed Care
Conference Insider
Care Coordination Teams: A Managed Care Approach
05/23/2011
Tori Socha
Organizing care involves the marshalling of personnel and other resources needed to carry out all required patient care activities.
Organizing care involves the marshalling of personnel and other resources needed to carry out all required patient care activities.
Organizing care involves the...
05/23/2011
First Report Managed Care
Conference Insider
The Current State of National Health Information Technology
05/23/2011
Tori Socha
The Affordable Care Act of 2010 places emphasis on the use of health information technology and its potential to reduce healthcare costs and improve health outcomes. 
The Affordable Care Act of 2010 places emphasis on the use of health information technology and its potential to reduce healthcare costs and improve health outcomes. 
The Affordable Care Act of 2010...
05/23/2011
First Report Managed Care
Conference Insider
Anticoagulation Therapies for Thromboembolic Disorders
05/23/2011
Tim Casey
Minneapolis—Approved by the US Food and Drug Administration (FDA) in 1954, warfarin has been the standard of care for decades for many patients with thromboembolic disorders. Still, some physicians are reluctant to prescribe warfarin because...
Minneapolis—Approved by the US Food and Drug Administration (FDA) in 1954, warfarin has been the standard of care for decades for many patients with thromboembolic disorders. Still, some physicians are reluctant to prescribe warfarin because...
Minneapolis—Approved by the US...
05/23/2011
First Report Managed Care
Conference Insider
Medication Therapy Management beyond Medicare Part D
05/23/2011
Tori Socha
Minneapolis—At a pharmacy partnership briefing session at the AMCP meeting, 2 pharmacists discussed medication therapy management (MTM) as it relates to Medicare Part D in a presentation titled MTM: Medicare Part D and Beyond. Jessica Frank,...
Minneapolis—At a pharmacy partnership briefing session at the AMCP meeting, 2 pharmacists discussed medication therapy management (MTM) as it relates to Medicare Part D in a presentation titled MTM: Medicare Part D and Beyond. Jessica Frank,...
Minneapolis—At a pharmacy...
05/23/2011
First Report Managed Care
Department
Update on Pharmaceutical Pipeline
05/23/2011
Tim Casey
The number of products in the pharmaceutical pipeline is less than it was from 2007 through 2009.
The number of products in the pharmaceutical pipeline is less than it was from 2007 through 2009.
The number of products in the...
05/23/2011
First Report Managed Care
Feature
Initiation of Pregabalin Fails to Reduce Per Patient Prescription Rates and Costs
05/23/2011
Christin Melton
Minneapolis—The initiation of pregabalin, which is typically prescribed as adjunctive therapy in patients who experience seizures and as relief for neuropathic pain in patients with diabetes, postherpetic neuralgia, or fibromyalgia,...
Minneapolis—The initiation of pregabalin, which is typically prescribed as adjunctive therapy in patients who experience seizures and as relief for neuropathic pain in patients with diabetes, postherpetic neuralgia, or fibromyalgia,...
Minneapolis—The initiation of...
05/23/2011
First Report Managed Care
Feature
Growth in Generics and Specialty Drugs
05/23/2011
Mary Beth Nierengarten
Minneapolis—Although growth in the US pharmaceutical market slowed from a 5.2% sales increase in 2009 to a 2.3% sales increase in 2010, the market was “pretty resilient,” according to Doug Long, MBA, vice president of industry relations at...
Minneapolis—Although growth in the US pharmaceutical market slowed from a 5.2% sales increase in 2009 to a 2.3% sales increase in 2010, the market was “pretty resilient,” according to Doug Long, MBA, vice president of industry relations at...
Minneapolis—Although growth in...
05/23/2011
First Report Managed Care
Feature
The Minnesota Community Measurement
05/23/2011
Mary Beth Nierengarten
A community healthcare initiative in Minnesota is showing that strong collaboration and sharing of information among all key stakeholders can improve outcomes.
A community healthcare initiative in Minnesota is showing that strong collaboration and sharing of information among all key stakeholders can improve outcomes.
A community healthcare...
05/23/2011
First Report Managed Care
Feature
Quality Initiatives in Managing Multiple Sclerosis
05/23/2011
Tim Casey
Minneapolis—The US Food and Drug Administration has approved several drugs in recent years to treat multiple sclerosis (MS), including fingolimod, the first oral MS therapy. There are also 5 drugs in phase 3 trials intended to treat MS.
Minneapolis—The US Food and Drug Administration has approved several drugs in recent years to treat multiple sclerosis (MS), including fingolimod, the first oral MS therapy. There are also 5 drugs in phase 3 trials intended to treat MS.
Minneapolis—The US Food and Drug...
05/23/2011
First Report Managed Care
Feature
Medication Adherence among Patients with Diabetes in a Managed Care Setting
05/23/2011
Tori Socha
Minneapolis—It is estimated that only about 50% of patients in the United States take their medications as prescribed. Poor adherence to medication regimens has been shown to have an impact on healthcare costs; approximately $150 billion in...
Minneapolis—It is estimated that only about 50% of patients in the United States take their medications as prescribed. Poor adherence to medication regimens has been shown to have an impact on healthcare costs; approximately $150 billion in...
Minneapolis—It is estimated that...
05/23/2011
First Report Managed Care
Feature
REMS Programs: Trends and Opportunities for Pharmacists
05/23/2011
Tori Socha
Minneapolis—The drug safety initiatives known as risk evaluation and mitigation strategies (REMS) have evolved over the past 30 years. From 1970 to 2005, drug safety measures largely focused on premarketing and risk assessment. From 2005 to...
Minneapolis—The drug safety initiatives known as risk evaluation and mitigation strategies (REMS) have evolved over the past 30 years. From 1970 to 2005, drug safety measures largely focused on premarketing and risk assessment. From 2005 to...
Minneapolis—The drug safety...
05/23/2011
First Report Managed Care
Feature
Low Adherence Rates to Atypical Antipsychotic Therapy in Patients with Schizophrenia
05/23/2011
Christin Melton
Minneapolis—A retrospective database study of insurance claims for 63,000 adults with schizophrenia who were prescribed certain oral atypical antipsychotic (AA) medications found that less than one-third (approximately 29.4%) remained...
Minneapolis—A retrospective database study of insurance claims for 63,000 adults with schizophrenia who were prescribed certain oral atypical antipsychotic (AA) medications found that less than one-third (approximately 29.4%) remained...
Minneapolis—A retrospective...
05/23/2011
First Report Managed Care
Feature
Risk-Sharing, Outcomes-Based Contracting Can Increase Accountability in Healthcare
05/23/2011
Jill Sederstorm
Minneapolis—As the healthcare industry continues to evolve, risk-sharing programs and outcomes-based contracting are placing an increased emphasis on accountability. These concepts were discussed during a contemporary issues session at the...
Minneapolis—As the healthcare industry continues to evolve, risk-sharing programs and outcomes-based contracting are placing an increased emphasis on accountability. These concepts were discussed during a contemporary issues session at the...
Minneapolis—As the healthcare...
05/23/2011
First Report Managed Care
Feature
Quantifying the Cost of Warfarin-Related Bleeding Events in Patients with Atrial Fibrillation
05/23/2011
Christin Melton
Warfarin prophylaxis reduces the rates of primary and secondary stroke in patients with atrial fibrillation (AF), but at a cost.
Warfarin prophylaxis reduces the rates of primary and secondary stroke in patients with atrial fibrillation (AF), but at a cost.
Warfarin prophylaxis reduces the...
05/23/2011
First Report Managed Care
Feature
Management Strategies for Hematologic Malignancies
05/23/2011
Tim Casey
Minneapolis—With the introduction of novel agents, healthcare professionals and managed care organizations are determining how to evaluate the new therapies and incorporate them into effective benefit designs. The agents are becoming more...
Minneapolis—With the introduction of novel agents, healthcare professionals and managed care organizations are determining how to evaluate the new therapies and incorporate them into effective benefit designs. The agents are becoming more...
Minneapolis—With the...
05/23/2011
First Report Managed Care
Feature
Cost-Effectiveness and Efficacy of Natalizumab versus Fingolimod
05/23/2011
Tori Socha
Minneapolis—Multiple sclerosis (MS) is a chronic, disabling disease of the central nervous system. It affects approximately 400,000 patients in the United States. The most commonly diagnosed category of MS is relapsing-remitting multiple...
Minneapolis—Multiple sclerosis (MS) is a chronic, disabling disease of the central nervous system. It affects approximately 400,000 patients in the United States. The most commonly diagnosed category of MS is relapsing-remitting multiple...
Minneapolis—Multiple sclerosis...
05/23/2011
First Report Managed Care
Conference Insider
Costs of Switching TNF Agents versus Dose Escalation
05/23/2011
Tori Socha
Minneapolis—As patients and physicians seek improved disease control, switching among anti–tumor necrosis factor (TNF) agents has become common practice, according to the authors of a recent study. Study results were presented at an AMCP...
Minneapolis—As patients and physicians seek improved disease control, switching among anti–tumor necrosis factor (TNF) agents has become common practice, according to the authors of a recent study. Study results were presented at an AMCP...
Minneapolis—As patients and...
05/23/2011
First Report Managed Care
Feature
Managed Care’s Role in Oncology
05/23/2011
Tim Casey
Minneapolis—In recent years, pharmaceutical companies have developed numerous expensive oncology drugs to stabilize patients with cancer, a trend expected to continue throughout this decade. Although the majority of products are covered under...
Minneapolis—In recent years, pharmaceutical companies have developed numerous expensive oncology drugs to stabilize patients with cancer, a trend expected to continue throughout this decade. Although the majority of products are covered under...
Minneapolis—In recent years,...
05/23/2011
First Report Managed Care
Feature
Barriers and Facilitators to Medication Adherence
05/23/2011
Tori Socha
Minneapolis—Patient adherence to prescribed medications has been well documented as an important issue in containing overall costs. Researchers recently conducted a survey of adherent and nonadherent patients to aid in understanding the...
Minneapolis—Patient adherence to prescribed medications has been well documented as an important issue in containing overall costs. Researchers recently conducted a survey of adherent and nonadherent patients to aid in understanding the...
Minneapolis—Patient adherence to...
05/23/2011
First Report Managed Care
Feature
More than a Year Later, Affordable Care Act Still a Major Issue
05/23/2011
Tim Casey
Since President Barack Obama signed the Patient Protection and Affordable Care Act (ACA) into law in March 2010, several provisions of the legislation have been enacted. However, healthcare reform remains a divisive political issue, consumer...
Since President Barack Obama signed the Patient Protection and Affordable Care Act (ACA) into law in March 2010, several provisions of the legislation have been enacted. However, healthcare reform remains a divisive political issue, consumer...
Since President Barack Obama...
05/23/2011
First Report Managed Care

Pipeline Projections

PIPELINE PROJECTIONS
Emerging Therapies Reshaping Atopic Dermatitis Care
03/26/2026
Roy Moore
Roy Moore outlines how a rapidly expanding atopic dermatitis pipeline is intensifying competition, reshaping payer strategies, and raising the bar for new therapies.
Roy Moore outlines how a rapidly expanding atopic dermatitis pipeline is intensifying competition, reshaping payer strategies, and raising the bar for new therapies.
Roy Moore outlines how a rapidly...
03/26/2026
First Report Managed Care
Pipe
Pipeline Projections
Emerging Migraine Treatments Challenge a Mature Market
11/20/2025
Roy Moore
Roy Moore of Clarivate’s market access team discussed the evolving migraine treatment landscape, highlighting the maturation of the acute and prophylactic markets, the emergence of new therapies such as triptan-COX-2 combinations, gepants,...
Roy Moore of Clarivate’s market access team discussed the evolving migraine treatment landscape, highlighting the maturation of the acute and prophylactic markets, the emergence of new therapies such as triptan-COX-2 combinations, gepants,...
Roy Moore of Clarivate’s market...
11/20/2025
First Report Managed Care
Pipeline Projections
Pipeline Projections
Redefining Asthma Management With Emerging Anti-Inflammatories
10/01/2025
Roy Moore
Roy Moore, a market access expert, discusses the evolving asthma drug pipeline, highlighting upcoming therapies—including Breztri, depemokimab, and masitinib—their potential to improve adherence and outcomes, payer considerations around cost...
Roy Moore, a market access expert, discusses the evolving asthma drug pipeline, highlighting upcoming therapies—including Breztri, depemokimab, and masitinib—their potential to improve adherence and outcomes, payer considerations around cost...
Roy Moore, a market access...
10/01/2025
First Report Managed Care
Pipeline Projections
The Shift in MS Care as Biologics and BTK Inhibitors Advance
07/25/2025
Roy Moore
In this edition of Pipeline Projections, Roy Moore breaks down the rapidly evolving landscape of multiple sclerosis treatments—highlighting the shift from injectables to orals, the rise of monoclonal antibodies, and the promise of innovative...
In this edition of Pipeline Projections, Roy Moore breaks down the rapidly evolving landscape of multiple sclerosis treatments—highlighting the shift from injectables to orals, the rise of monoclonal antibodies, and the promise of innovative...
In this edition of Pipeline...
07/25/2025
First Report Managed Care
Pipeline Projections
How Biosimilars Are Shaping RA Treatment and Reimbursement Strategies
04/29/2025
Roy Moore
In this episode of Pipeline Projections, Roy Moore—Senior Healthcare Research & Data Analyst at Clarivate—discusses the expanding biosimilar pipeline for autoimmune diseases. He highlights recent FDA approvals, formulary and pricing...
In this episode of Pipeline Projections, Roy Moore—Senior Healthcare Research & Data Analyst at Clarivate—discusses the expanding biosimilar pipeline for autoimmune diseases. He highlights recent FDA approvals, formulary and pricing...
In this episode of Pipeline...
04/29/2025
First Report Managed Care

Subscribe to receive the latest updates in managed care!

First Report Managed Care Newsletter

Behind the Bill

Behind the Bill
HHS Hits Reset on 340B Rebate Model After Court Setbacks
02/11/2026
Juliet Gallagher
The US Department of Health and Human Services (HHS) has formally scrapped its 340B Rebate Model Pilot Program following a series of court rulings that blocked its implementation—signaling a significant pause in one of the most closely...
The US Department of Health and Human Services (HHS) has formally scrapped its 340B Rebate Model Pilot Program following a series of court rulings that blocked its implementation—signaling a significant pause in one of the most closely...
The US Department of Health and...
02/11/2026
First Report Managed Care
Behind the Bill
Funding Package Extends Medicare Telehealth, Enacts PBM Reforms, and Updates Hospital Oversight
02/05/2026
Juliet Gallagher
On February 3, 2026, President Donald Trump signed a broad government funding package that includes multi-year extensions for Medicare teleath and hospital-at-home programs, new oversight requirements for pharmacy benefit managers (PBMs), and...
On February 3, 2026, President Donald Trump signed a broad government funding package that includes multi-year extensions for Medicare teleath and hospital-at-home programs, new oversight requirements for pharmacy benefit managers (PBMs), and...
On February 3, 2026, President...
02/05/2026
First Report Managed Care
Behind the Bill
The Senate’s $3 Trillion Deal. Tax Relief Now, Medicaid Coverage Loss Later?
07/02/2025
Katie Hayes, MJ
The Senate has done it. After weeks of behind-the-scenes wrangling and last-minute amendments, lawmakers have passed a sprawling tax-and-spending megabill that makes good on a long-standing Republican goal: making the 2017 Trump tax cuts...
The Senate has done it. After weeks of behind-the-scenes wrangling and last-minute amendments, lawmakers have passed a sprawling tax-and-spending megabill that makes good on a long-standing Republican goal: making the 2017 Trump tax cuts...
The Senate has done it. After...
07/02/2025
First Report Managed Care
Behind the Bill
When a Cap Isn’t Just a Cap: How a Provider Tax Proposal Could Reshape Medicaid Financing
06/25/2025
Katie Hayes, MJ
In Washington, the most consequential policies are often buried in the fine print. One such detail in the Senate Finance Committee’s latest tax and spending proposal would gradually cap provider taxes—a core funding tool states use to pull in...
In Washington, the most consequential policies are often buried in the fine print. One such detail in the Senate Finance Committee’s latest tax and spending proposal would gradually cap provider taxes—a core funding tool states use to pull in...
In Washington, the most...
06/25/2025
First Report Managed Care
Behind the Bill
Rewriting the Safety Net? Inside the Senate’s Changes to Medicaid and the ACA
06/18/2025
Katie Hayes, MJ
Over the past few weeks, I’ve been following the progress of the One Big Beautiful Bill Act (OBBBA), which started in the House with sweeping tax reforms and some eye-catching health care proposals. Now, the Senate has released its (highly...
Over the past few weeks, I’ve been following the progress of the One Big Beautiful Bill Act (OBBBA), which started in the House with sweeping tax reforms and some eye-catching health care proposals. Now, the Senate has released its (highly...
Over the past few weeks, I’ve...
06/18/2025
First Report Managed Care
Behind the Bill
How States Might Respond to the One Big Beautiful Bill Act
06/11/2025
Katie Hayes, MJ
With the One Big Beautiful Bill Act (OBBBA) still in the hands of the Senate, much of the national conversation has centered on what this legislation would do to federal coverage programs. But regardless of how the federal process unfolds,...
With the One Big Beautiful Bill Act (OBBBA) still in the hands of the Senate, much of the national conversation has centered on what this legislation would do to federal coverage programs. But regardless of how the federal process unfolds,...
With the One Big Beautiful Bill...
06/11/2025
First Report Managed Care
Behind the Bill
Is the Affordable Care Act on the Chopping Block? What the One Big Beautiful Bill Act Tells Us.
06/04/2025
Katie Hayes, MJ
It’s been weeks of headline-grabbing debate over Medicaid work requirements, and the “One Big Beautiful Bill Act” remains in the Senate as they deliberate over several health care provisions. While the Medicaid provisions sparked most of the...
It’s been weeks of headline-grabbing debate over Medicaid work requirements, and the “One Big Beautiful Bill Act” remains in the Senate as they deliberate over several health care provisions. While the Medicaid provisions sparked most of the...
It’s been weeks of...
06/04/2025
First Report Managed Care
Behind the Bill
From House to Senate: The Journey of Cutting Medicaid
05/28/2025
Katie Hayes, MJ
Last week, the House of Representatives narrowly passed the One Big Beautiful Bill Act (HR 1, 119th Congress) by a single vote, sending the sweeping tax and spending reconciliation package, backed by President Trump, to the Senate. With its...
Last week, the House of Representatives narrowly passed the One Big Beautiful Bill Act (HR 1, 119th Congress) by a single vote, sending the sweeping tax and spending reconciliation package, backed by President Trump, to the Senate. With its...
Last week, the House of...
05/28/2025
First Report Managed Care
Behind the Bill
Eligibility, Paperwork, and Penalties: The Not-So-Hidden Costs of Medicaid ‘Reform’
05/21/2025
Katie Hayes, MJ
It’s been another eventful week in health policy—a phrase that’s quickly becoming routine. This time, House Republicans advanced a sweeping budget reconciliation bill, designed to implement elements of the March budget resolution, with a...
It’s been another eventful week in health policy—a phrase that’s quickly becoming routine. This time, House Republicans advanced a sweeping budget reconciliation bill, designed to implement elements of the March budget resolution, with a...
It’s been another eventful week...
05/21/2025
First Report Managed Care
Behind the Bill
A Busy Week in Drug Pricing Policy: Aligning US Drug Prices With Global Standards?
05/14/2025
Katie Hayes, MJ
It’s been a busy few days for drug pricing policy. While I’d love to dig into the details of both President Trump’s latest executive order and the newest Republican bill that would cut Medicaid spending, we don’t have the time—and this isn’t...
It’s been a busy few days for drug pricing policy. While I’d love to dig into the details of both President Trump’s latest executive order and the newest Republican bill that would cut Medicaid spending, we don’t have the time—and this isn’t...
It’s been a busy few days for...
05/14/2025
First Report Managed Care

May 2011 Volume 8 Issue 5

View Issue Archive
Editorial Correspondence

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use